Orbital infections and inflammations

Current Opinion in Ophthalmology

Volumn 9, Issue 5, 1998, Pages 41-48

  Shovlin, Joseph P ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIBIOTIC AGENT; CEPHALOSPORIN; CLINDAMYCIN; CORTICOSTEROID; DECONGESTIVE AGENT; IBUPROFEN; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; PREDNISOLONE; SULTAMICILLIN;

BACTERIAL INFECTION; CLINICAL EXAMINATION; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DEBRIDEMENT; HAEMOPHILUS INFLUENZAE; HISTOPATHOLOGY; HUMAN; IDIOPATHIC DISEASE; IMMUNE DEFICIENCY; INTRANASAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; META ANALYSIS; MINIMALLY INVASIVE SURGERY; MYCOSIS; MYOSITIS; ORBIT CELLULITIS; ORBIT INFECTION; OSTEOMYELITIS; PARANASAL SINUS DISEASE; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; SURGICAL DRAINAGE; TREATMENT OUTCOME; WEGENER GRANULOMATOSIS;

CELLULITIS; DIAGNOSIS, DIFFERENTIAL; EYE INFECTIONS; HUMANS; MYOSITIS; ORBITAL DISEASES; SINUSITIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0031766041     PISSN: 10408738     EISSN: None     Source Type: Journal    
DOI: 10.1097/00055735-199810000-00009     Document Type: Review

References (19)

1. Healy GB: The pathogenesis of orbital complications in acute sinusitis. Laryngoscope 1997, 107:441-446. Reports the advancements in the understanding of the pathogenesis and treatment of the orbital complications of sinus disease since Chandler's classic article published in 1970. The article emphasizes the role of ethmoid sinusitis in the development of orbital cellulitis. The most common pathogens identified in acute suppurative sinusitis have not changed, but Branhamella catarrhalis has become more common especially in children. The author warns against treating these infections in the ambulatory setting.
2. Nash E, Livingston P, Margo CE: Orbital cellulitis in the acquired immunodeficiency syndrome. Arch Ophthalmol 1997, 115:677-678.
3. Barone SR, Aiuto LT: Periorbital and orbital cellulitis in the Haemophilus influenzae vaccine era. J Pediatr Ophthalmol Strabismus 1997, 34:293-296. The authors point out the changing bacteriology of periorbital and orbital infections in the era of vaccination. This report confirms that vaccination does limit potentially serious infections.
4. Froehlich P, Pransky SM, Fontaine P, Stearns G, Morgon A: Minimal endoscopie approach to subperiosteal orbital abscess. Arch Otolaryngol Head Neck Surg 1997, 123:280-282.
5. Brook I, Frazier EH: Aerobic and anaerobic microbiology of dacryocystitis. Am J Ophthalmol 1998, 125:552-554.
6. Mauriello JA, Wasserman BA: Acute dacryocystitis: an unusual cause of life-threatening orbital intraconal abscess with frozen globe. Ophthal Plast Reconstr Surg 1996, 12:294-295.
7. El-Toukhy E, Szal M, Levine MR, Levine HL: Osteomyelitis of the orbit. Ophthal Plast Reconstr Surg 1997, 13:68-71.
8. Balch K, Phillips PH, Newman NJ: Painless orbital apex syndrome from mucormycosis. J Neuroophthal 1997, 17:178-182.
9. Harrison AR, Wirtschafter JD: Ocular neuromyotonia in a patient with cavernous sinus thrombosis secondary to mucormycosis. Am J Ophthalmol 1997, 124:122-123.
10. Deshazo RD, Chapin K, Swain RE: Current concepts: fungal sinusitis. N Engl J Med 1997, 337:1491-1494. This article provides an excellent overview of fungal sinusitis as well as the potentially life-threatening complications. The article describes the risk factors in patients who develop fungal sinusitis and subsequent orbital invasion. The authors point out the need for aggressive management of these potentially life-threatening infections.
11. Mombaerts I, Koornneef L: Current status in the treatment of orbital myositis. Ophthalmology 1997, 104:402-408. The authors describe the clinical characteristics of orbital myositis along with the outcomes of corticosteroid and radiation therapy. Significant findings include a 50% recurrence rate as well as failure of 20 Gy of radiotherapy to prevent recurrence. The authors also distinguish the clinical characteristics of orbital myositis and diffuse idiopathic orbital inflammation.
12. Artlett CM, Smith JB, Jimenez SA: Identification of fetal DNA and cells in skin lesions from women with systemic sclerosis. N Engl J Med 1998, 338:1186-1191.
13. Mannor GE, Rose GE, Moseley IF, Wright JE: Outcome of orbital myositis: clinical features associated with recurrence. Ophthalmology 1997, 104:409-413.
14. Kennerdell JS: Discussion. Ophthalmology 1997, 104:414.
15. Mauriello JA, Piacentini M, Pokorny KS, Mostafavi R, Yepez M, Leone T: The role of proliferating nuclear antigen (PCNA) in differentiating idiopathic orbital inflammatory disease and lymphoid proliferations. Ophthal Plast Reconstr Surg 1987, 13:26-30.
16. Perry SR, Rootman J, White VA: The clinical and pathologic constellation of Wegener granulomatosis ot the orbit. Ophthalmology 1997, 104:683-694. Describes in detail the clinical findings in patients with Wegener granulomatosis affecting the orbit. Orbital Wegener granulomatosis can be identified by a constellation of clinical and radiographic findings. Prompt recognition of this condition is required to initiate potentially life-saving therapy.
17. Jayne DRW, Rasmussen N, Abramowicz D et al: Treatment of antineutrophil cytoplasm autoantibody associated systemic vasculitis: initiatives of the European community systemic vasculitis clinical trials study group. Mayo Clin Proc 1997, 72:990-995.
18. Adachi JD, Bensen WG, Brown J, Hanley D, Hodsman A, Josse R, et al.: Intermittent etidronate therapy to prevent corticosteroid induced osteoporosis. N Engl J Med 1997, 337:382-387.
19. Langford JD, McCartney DL, Wang RC: Frozen section-guided surgical debridement for the management of rhino-orbital mucormyosis. Am J Ophthalmol 1997, 124:265-267.